RLN2 and essential hypertension: Considering this evidence, relaxin-2 levels could be employed as a promising biomarker for the early detection of essential hypertension and concurrent cardiovascular events, and for categorizing children and young adults according to their cardiovascular risk as a basis for the prevention of adult cardiac disorders.